1-4 of 4
Heng Joo Ng, MD
Close
Sort by
Journal Articles

Factor V Leiden and Prothrombin G20210A Gene Mutations Should Not Be Routinely Screened among Venous Thromboembolism (VTE) Patients in Singapore - This and Patterns of Other Thrombophilic Conditions among Our VTE Patients.

Heng Joo Ng, MD, Lai Heng Lee, MD, Te-Chih Liu, MD, Lip Kun Tan, MD, Ponnudurai Kuperan, MD
Journal: Blood
Blood (2006) 108 (11): 4087.
https://doi.org/10.1182/blood.V108.11.4087.4087
Published: 2006
Journal Articles

Use of Immunoglobulin Infusions in the Management of Bortezomib-Induced Peripheral Neuropathy in Multiple Myeloma.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD
Journal: Blood
Blood (2006) 108 (11): 5097.
https://doi.org/10.1182/blood.V108.11.5097.5097
Published: 2006
Journal Articles

Factors Influencing Responsiveness to Bortezomib in Patients with Multiple Myeloma Suggest a Possible Role for Host Immunocompetency.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD
Journal: Blood
Blood (2006) 108 (11): 5100.
https://doi.org/10.1182/blood.V108.11.5100.5100
Published: 2006
Journal Articles

High Response and Complete Remission Rates in Relapsed/Refractory Multiple Myeloma Treated with Bortezomib, Thalidomide, Dexamethasone and Zoledronic Acid (VTD-Z) Combination Therapy.

Gerrard Teoh, MD, Daryl Tan, MD, William Hwang, MD, Liang Piu Koh, MD, Charles Chuah, MD, Heng Joo Ng, MD
Journal: Blood
Blood (2005) 106 (11): 5127.
https://doi.org/10.1182/blood.V106.11.5127.5127
Published: 2005